Suppression of FTO significantly stabilizes apolipoprotein E (APOE) mRNA and coordinates with IGF2BP2, leading to the promotion of GLUT1 expression and tumor glycolysis by modulating the IL-6/JAK2/STAT3 signaling pathway [172]. The gene discussed is FTO; the disease is neoplasm.